Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells

Cancer Letters

Volumn 285, Issue 2, 2009, Pages 190-199

  Li, Mengsen ^a,b   Li, Hui ^a   Li, Chaoying ^a   Guo, Liyuan ^a   Liu, Han ^a   Zhou, Sheng ^b   Liu, Xinhua ^a   Chen, Zhuo ^a   Shi, Shuanglin ^c   Wei, Jiang ^a   McNutt, Michael A ^a   Li, Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c BEIHUA UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Alpha fetoprotein; Apoptosis; Hepatoma; Nuclear receptor

Indexed keywords

ALPHA FETOPROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RESISTANCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG RECEPTOR BINDING; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ALPHA-FETOPROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOPLASM; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; IMMUNOPRECIPITATION; LIVER NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN TRANSPORT; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TRANSFECTION; TRETINOIN;

EID: 70349960049     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.05.014     Document Type: Article

References (51)

1. Toder V., Blank M., Goldgefter L., and Nebel L. The effect of alpha-fetoprotein on the growth of placental cells in vitro. Placenta 4 (1983) 79-85
2. Liu Y., Daley S., Evdokimova V.N., Zdobinski D.D., Potter D.A., and Butterfield L.H. Hierarchy of a fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer. Journal of Immunology 177 (2006) 712-721
3. Koide N., Nishio A., Igarashi J., Kajikawa S., Adachi W., and Amano J. Alpha-fetoprotein-producing gastric cancer: histochemical analysis of cell proliferation, apoptosis, and angiogenesis. American Journal of Gastroenterology 94 (1999) 1658-1663
4. Amemiya H., Kono K., Mori Y., Takahashi A., Ichihara F., Iizuka H., and Sekikawa T. High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 59 (2000) 145-151
5. Bennett J.A., Semeniuk D.J., Jacobson H.I., and Murgita R.A. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth. Breast Cancer Research and Treatment 45 (1997) 169-179
6. Dudich E., Semenkova L., Gorbatova E., Dudich I., Khromykh L., Tatulov E., Grechko G., and Sukhikh G. Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumor Biology 19 (1998) 30-40
7. Li M.S., Li P.F., He S.P., Du G.G., and Li G. The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World Journal of Gastroenterology 8 (2002) 469-475
8. Li M.S., Li P.F., Yang F.Y., He S.P., Du G.G., and Li G. The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells. Cell Research 12 (2002) 151-156
9. Terentiev A.A., and Moldogazieva N.T. Cell adhesion proteins and alpha-fetoprotein. Similar structural motifs as prerequisites for common functions. Biochemistry-Moscow 72 (2007) 920-935
10. Mizejewski G.J. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Review of Anticancer Therapy 2 (2002) 709-735
11. Mizejewski G.J., and Butterstein G. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects. Current Protein & Peptide Science 7 (2006) 73-100
12. Newby D., Daigliesh G., Lyall F., and Aitken D.A. Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term. Placenta 26 (2005) 190-200
13. Tsuboi S., Taketa K., Nouso K., Fujikawa T., Manabe K., Ohmori H., Higashi T., and Shiratori Y. High level of expression of alpha-fetoprotein receptor in gastric cancers. Tumor Biology 27 (2006) 283-288
14. Moro R., Tamaoki T., Wegmann T.G., Longenecker B.M., and Laderoute M.P. Monoclonal-antibodies derected against a widespread oncofetal antigen - the alpha fetoprotein receptor. Tumor Biology 14 (1993) 116-130
15. Parikh R.R., Gildener-Leapman N., Narendran A., Lin H.Y., Lemanski N., Bennett J.A., Jacobson H.I., and Andersen T.T. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP. Clinical Cancer Research 11 (2005) 8512-8520
16. Torres J.M., Euskens M., and Uriel J. Activated human T lymphocytes express albumin binding proteins which cross-react with alpha fetoprotein. European Journal of Cell Biology 57 (1992) 222-228
17. Laderoute M., Willans D., Wegmann T., and Longenecker M. The identification, isolation and characterization of a 67-kilodalton, PNA-reactive autoantigen commonly expressed in human adenocarcinomas. Anticancer Research 14 (1994) 1233-1245
18. Lorenzo H.C., Geuskens M., Macho A., Lachkar S., VerdiereSahuque M., Pineiro A., and Uriel J. Alpha-fetoprotein binding and uptake by primary cultures of human skeletal muscle. Tumor Biology 17 (1996) 251-260
19. Kanevsky V.Y., Pozdnyakova L.P., Aksenova O.A., Severin S.E., Katukov V.Y., and Severin E.S. Isolation and characterization of AFP-binding proteins from tumor and fetal human tissues. Biochemistry and Molecular Biology International 41 (1997) 1143-1151
20. Semenkova L., Dudich E., Dudich I., Tokhtamisheva N., Tatulov E., Okruzhnov Y., Garcia-Foncillas J., Palop-Cubillo J.A., and Korpela T. Alpha-fetoprotein positively regulates cytochrome c-mediated caspase activation and apoptosome complex formation. European Journal of Biochemistry 270 (2003) 4388-4399
21. Dudich E., Semenkova L., Dudich I., Gorbatova E., Tochtamisheva N., Tatulov E., Nikolaeva M., and Sukhikh G. Alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases. European Journal of Biochemistry 266 (1999) 750-761
22. Li M.S., Liu X.H., Zhou S., Li P.F., and Li G. Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes. BMC Cancer 5 (2005)
23. Li M.S., Zhou S., Liu X.H., Li P.F., McNutt M.A., and Li G. Alpha-fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Letters 249 (2007) 227-234
24. Dauphinee M.J., and Mizejewski G.J. Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcript ion/growth factors. Medical Hypotheses 58 (2002) 453-461
25. Li M.S., Li H., Li C., Zhou S., Guo L., Liu H., Wei J., Liu X., Li P., McNutt M.A., and Li G. Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells. International Journal of Cancer 124 (2009) 2845-2854
26. Freemantle S.J., Spinella M.J., and Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22 (2003) 7305-7315
27. Muto Y., Moriwaki H., and Saito A. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. New England Journal of Medicine 340 (1999) 1046-1047
28. Wang L.H., and Levin M.S. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma. Gastroenterology 128 (2005) 228-231
29. Clerici C., Castellani D., Russo G., Fiorucci S., Sabatino G., Giuliano V., Gentili G., Morelli O., Raffo P., Baldoni M., Morelli A., and Toma S. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. Anticancer Research 24 (2004) 1255-1260
30. Thomas M.B., and Abbruzzese J.L. Opportunities for targeted therapies in hepatocellular carcinoma. Journal of Clinical Oncology 23 (2005) 8093-8108
31. Muto Y., Moriwaki H., Ninomiya M., Adachi S., Saito A., Takasaki K.T., Tanaka T., Tsurumi K., Okuno M., Tomita E., Nakamura T., and Kojima T. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. New England Journal of Medicine 334 (1996) 1561-1567
32. Li M.S., Li P.F., Chen Q., Du G.G., and Li G. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World Journal of Gastroenterology 10 (2004) 819-824
33. Wei E.M., Li P.F., Liu X.H., Qian C.W., Li H., Xia W.Y., and Li G. The potential promoter regions on the 5′ flank sequence of the mu opioid receptor gene in lymphocytes. Journal of Cellular Biochemistry 95 (2005) 1204-1213
34. You X., Nguyen A.W., Jabaiah A., Sheff M.A., Thorn K.S., and Daugherty P.S. Intracellular protein interaction mapping with FRET hybrids. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 18458-18463
35. Li H., Liu H., Wang Z., Liu X., Guo L., Huang L., Gao L., McNutt M.A., and Li G. The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes. Journal of Cellular Biochemistry 104 (2008) 237-250
36. Deutsch H.F. Chemistry and biology of alpha-fetoprotein. Advances in Cancer Research 56 (1991) 253-312
37. Gabant P., Forrester L., Nichols J., Van Reeth T., De Mees C., Pajack B., Watt A., Smitz J., Alexandre H., Szpirer C., and Szpirer J. Alpha-fetoprotein, the major fetal-serum protein, is not essential for embryonic development but is required for female fertility. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 12865-12870
38. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB Journal 10 (1996) 940-954
39. Mangelsdorf D.J. Vitamin A receptors. Nutrition Reviews 52 (1994) S32-S44
40. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamel Y., Soderstrom M., Glass C.K., and Rosenfeld M.G. Ligand-independent repression by the thyroid-hormone receptor-mediated by a nuclear receptor co-repressor. Nature 377 (1995) 397-404
41. Hermanson O., Glass C.K., and Rosenfeld M.G. Nuclear receptor coregulators: multiple modes of modification. Trends in Endocrinology and Metabolism 13 (2002) 55-60
42. Lin R., Nagai Y., Sladek R., Bastien Y., Ho J., Petrecca K., Sotiropoulou G., Diamandis E.P., Hudson T.J., and White J.H. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D-3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Molecular Endocrinology 16 (2002) 1243-1256
43. Frasor J., Danes J.M., Komm B., Chang K.C.N., Lyttle C.R., and Katzenellenbogen B.S. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144 (2003) 4562-4574
44. Chen H.M., Dong J.M., Liu Y., and Chiu J.F. Identification of a cis-acting element in the rat alpha-fetoprotein gene and its specific binding proteins in F9 cells during retinoic acid-induced differentiation. Journal of Cellular Biochemistry 72 (1999) 25-34
45. Liu Y., Chen H.M., and Chiu J.F. Identification of a retinoic acid response element upstream of the rat alpha-fetoprotein gene. Molecular and Cellular Endocrinology 103 (1994) 149-156
46. Ninomiya T., Mihara K., Fushimi K., Hayashi Y., Hashimoto-Tamaoki T., and Tamaoki T. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma. Hepatology 35 (2002) 82-87
47. Hajerigermond M., Naval J., Trojan J., and Uriel J. The uptake of alpha-fetoprotein by C-1300 mouse neuro-blastoma cells. British Journal of Cancer 51 (1985) 791-797
48. Adam S.A., and Gerace L. Cytosolic protein that specifically bind nuclear location signals are receptors for nuclear import. Cell 66 (1991) 837-847
49. David P.S., Tanveer R., and Port J.D. FRET-detectable interactions between the ARE binding proteins, HuR and p37AUF1. Rna-a Publication of the Rna Society 13 (2007) 1453-1468
50. Wang Y.S., Ma X.L., Qi T.G., Liu X.D., Meng Y.S., and Guan G.J. Downregulation of alpha-fetoprotein siRNA inhibits proliferation of SMMC-7721 cells. World Journal of Gastroenterology 11 (2005) 6053-6055
51. Heim K.C., White K.A., Deng D., Tomlinson C.R., Moore J.H., Freemantle S.J., and Spinella M.J. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells. Molecular Cancer 6 (2007)